# GlaxoSmithKline Pharmaceuticals S.A. - Inspection Records

Source: https://www.keypedia.com/companies/glaxosmithkline-pharmaceuticals-sa/72897bb1-65dd-45fe-b1f2-fe2091bc516c

> Inspection records and compliance data for GlaxoSmithKline Pharmaceuticals S.A. in Poznan, N/A. Access full analysis and detailed observations.

---

## Details

- Name: GlaxoSmithKline Pharmaceuticals S.A.
- City: Poznan
- State: N/A
- Country Name: Canada
- Address Line 1: Ul.Grunwaldzka 189
- Zip Code: 60-322

## Related Documents

- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #80366 - 2022-09-09](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/3205cb7a-4e6e-4b9e-b4f9-0d6a272bf934) — source: Canada, date: September 9, 2022
- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #80051 - 2021-11-18](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/cc36e477-e4c6-4b7e-adcc-850f23d6598e) — source: Canada, date: November 18, 2021
- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #73990 - 2019-06-07](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/c6012506-9a7a-4fb7-a210-a28a05eeb531) — source: Canada, date: June 7, 2019
- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #77814 - 2019-02-26](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/6ae4513a-e780-4959-9075-c098c0e4a464) — source: Canada, date: February 26, 2019
- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #68057 - 2017-04-28](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/a989e985-b249-44c0-be65-7da4499abcf2) — source: Canada, date: April 28, 2017
- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #64441 - 2016-11-18](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/b3afcb58-c6c7-47df-ad00-ac01e9f6e9eb) — source: Canada, date: November 18, 2016
- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #5801 - 2014-06-27](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/d41cbd09-98b9-489b-9997-b051b4a68395) — source: Canada, date: June 27, 2014
- [Canada Inspection - GlaxoSmithKline Pharmaceuticals S.A. - Inspection #1476 - 2012-02-24](https://www.keypedia.com/records/canada_inspection/glaxosmithkline-pharmaceuticals-sa/d4604f38-7499-4fec-9ef1-041a03d7ea93) — source: Canada, date: February 24, 2012

## Related Companies

- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/9cd488b4-245e-4f5e-b4d1-0503379dac9a)
- [Aurobindo Pharma Ltd. (Unit III)](https://www.keypedia.com/companies/aurobindo-pharma-ltd-unit-iii/a6d36541-ed8d-4fc3-b260-0e625bc2ee84)
- [Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/4487fe78-1069-45e8-b8c6-11e9fea04df4)
- [Indoco Remedies Limited](https://www.keypedia.com/companies/indoco-remedies-limited/95b6548a-6341-41ea-b7cb-31994562b461)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/264abfd9-9992-487c-892d-6b084f26dcad)
- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/fe1979d1-b128-4e9d-b9d6-66f300a27e9d)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/1f7f62b6-b4b3-4da1-9361-56eba81febba)
- [Medreich Ltd.](https://www.keypedia.com/companies/medreich-ltd/ee9759dc-e9d6-4b4d-800a-eba78831d0e9)
- [Jubilant Generics Limited](https://www.keypedia.com/companies/jubilant-generics-limited/f955c42c-e7fe-4c4f-bb82-80cb09c2600a)
- [Alphapharm Pty Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/10341988-5854-4909-8738-253d63b54391)